The Global Perspective on COVID-19 Vaccine Distribution

by MUZZAMMIL AHMADZADA, WAQAS HAQUE, & AHMAD AHMADZADA | The year 2020 will forever be remembered for how an outbreak of the SARS-CoV-2 virus—an infectious agent just under 90 nanometers in diameter—redefined institutions on an international level. What began as a “cluster of pneumonia cases” in Wuhan, China in January turned into a global pandemic resulting in 83.4 million cases of infection and over 1.82 million deaths at the time of this writing. Although various degrees of lockdown were implemented worldwide to reduce the spread of the highly contagious virus, it was evident that only a vaccine providing immunity to the general public would afford society a return to normalcy.